FORBES INDIA DAILY TECH CONVERSATION PODCAST | Anand Anandkumar, CEO of Bugworks Research, talks about the many challenges of commercializing scientific breakthroughs from India. He also talks about the opportunity for this country to become a biotech powerhouse. Bugworks is a clinical phase drug discovery company that is attempting to develop a new class of antibiotics to tackle antimicrobial resistance.